Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-01
1999-12-07
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514214, 514299, 514304, 514305, 514326, 514364, 514342, 540593, 546112, 546125, 546133, 546137, 546209, 5462691, 548125, C07D41312, A61K 31435
Patent
active
05998404&
ABSTRACT:
The present invention relates to therapeutically active azacyclic or azabicyclic compounds of formula I ##STR1## and to pharmaceutical formulations comprising these compounds and methods of treatment comprising administering these compounds to a subject in need of treatment. The novel oxadiazole compounds, such as (.+-.)-3-butyloxy-4-(1-azabicyclo[2.2.2]octyl-3-oxy)-1,2,5-oxadiazole, are useful in treating central nervous system disorders caused by malfunctioning of the muscarinic cholinergic system.
REFERENCES:
patent: 4837241 (1989-06-01), Sauerberg et al.
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
patent: 5082843 (1992-01-01), Cliffe
patent: 5260314 (1993-11-01), Sauerberg et al.
patent: 5286864 (1994-02-01), Walther
patent: 5328923 (1994-07-01), Sauerberg et al.
patent: 5328924 (1994-07-01), Sauerberg et al.
patent: 5414009 (1995-05-01), Olesen
patent: 5418240 (1995-05-01), Sauerberg et al.
patent: 5508405 (1996-04-01), Walther et al.
patent: 5605908 (1997-02-01), Merritt et al.
patent: 5665745 (1997-09-01), Alt et al.
patent: 5731323 (1998-03-01), Whittamore
patent: 5889019 (1999-03-01), Mitch
Derwent Abstract 18366B/10; Jul. 27, 1977.
Derwent Abstract 10251B/06; Jul. 8, 1977.
Derwent Abstract 88-256990/36; Feb. 27, 1987.
Mathew, et al., Am. J. Psychiatry, 137:9, 1118-1120 (1980).
Sim, M. and Houghton, H., J. of Nervous and Mental Disease, 143:6, 484-491 (1966).
Rapaport, et al., Biol. Psychiatry, 29, 658-664 (1991).
Chemical Abstracts, 117:No. 26428 (1992).
Ward, et al., J. Med. Chem., 35, pp. 4011-4019 (1992).
Quirion, et al., Tips, pp. 80-84 (1989).
Newhouse, et al., Drug Development Research, 38, pp. 278-289 (1996).
Aubert, et al., J. of Neurochemistry, "Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases," pp. 529-541 (1992).
Katzung, B.G., Basic & Clinical Pharmacology, (Appleton & Lange, Norwalk), pp. 92-94 (1995).
Merritt Leander
Ward John S.
Bernhardt Emily
Eli Lilly and Company
Stermerick David M.
Vorndran-Jones MaCharri
LandOfFree
Heterocyclic compounds and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-823976